论文部分内容阅读
应用特异性抗病毒免疫核糖核酸治疗病毒性肺炎,检测了治疗前、后患儿外周血白细胞介素-2活性。结果麦明:特异性iRNA可以使患儿外周血IL-2活性升高,与对照组相比有显著差异。同时对iRNA的临床疗效进行初步观察,观察组患儿主要临床症状和体征消失的时间均明显短于对照组,说明特异性抗病毒iRNA临床有效。
Application of specific anti-viral ribonucleic acid in the treatment of viral pneumonia, detection of peripheral blood before and after treatment, interleukin-2 activity. Results Maoming: Specific iRNA can increase the level of IL-2 in peripheral blood of children with significant difference compared with the control group. At the same time, the clinical efficacy of iRNA was initially observed. The main clinical symptoms and signs disappeared in the observation group were significantly shorter than the control group, indicating that the specific anti-viral iRNA clinical effective.